Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA

Yulia Korshunova, Rebecca K. Maloney, Nathan Lakey, Robert W. Citek, Blaire Bacher, Arief Budiman, Jared M. Ordway, W. Richard McCombie, Jorge Leon, Jeffrey A. Jeddeloh, John Douglas Mcpherson

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Cytosine-methylation changes are stable and thought to be among the earliest events in tumorigenesis. Theoretically, DNA carrying tumor-specifying methylation patterns escape the tumors and may be found circulating in the sera from cancer patients, thus providing the basis for development of noninvasive clinical tests for early cancer detection. Indeed, using methylation-specific PCR-based techniques, several groups reported the detection of tumor-associated methylated DNA in the sera from cancer patients with varying clinical success. However, by design, such analytical approaches allow assessment of the presence of molecules with only one methylation pattern, leaving the bigger picture unexplored. The limited knowledge about circulating DNA methylation patterns hinders the efficient development of clinical methylation tests and testing platforms. Here, we report the results of a comprehensive methylation pattern analysis from breast cancer clinical tissues and sera obtained using massively parallel bisulphite pyrosequencing. The four loci studied were recently discovered by our group, and demonstrated to be powerful epigenetic biomarkers of breast cancer. The detailed analysis of more than 700,000 DNA fragments derived from more than 50 individuals (cancer and cancer-free) revealed an unappreciated complexity of genomic cytosine-methylation patterns in both tissue derived and circulating DNAs. Both tumor and cancer-free tissues (as well as sera) contained molecules with nearly every conceivable cytosine-methylation pattern at each locus. Tumor samples displayed more variation in methylation level than normal samples. Importantly, by establishing the methylation landscape within circulating DNA, this study has better defined the development challenges facing DNA methylation-based cancer-detection tests.

Original languageEnglish (US)
Pages (from-to)19-29
Number of pages11
JournalGenome Research
Volume18
Issue number1
DOIs
StatePublished - Jan 2008
Externally publishedYes

Fingerprint

Cytosine
Methylation
Breast Neoplasms
DNA
Serum
Neoplasms
DNA Methylation
Tumor Escape
Early Detection of Cancer
Epigenomics
Carcinogenesis
Biomarkers
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Genetics

Cite this

Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. / Korshunova, Yulia; Maloney, Rebecca K.; Lakey, Nathan; Citek, Robert W.; Bacher, Blaire; Budiman, Arief; Ordway, Jared M.; McCombie, W. Richard; Leon, Jorge; Jeddeloh, Jeffrey A.; Mcpherson, John Douglas.

In: Genome Research, Vol. 18, No. 1, 01.2008, p. 19-29.

Research output: Contribution to journalArticle

Korshunova, Y, Maloney, RK, Lakey, N, Citek, RW, Bacher, B, Budiman, A, Ordway, JM, McCombie, WR, Leon, J, Jeddeloh, JA & Mcpherson, JD 2008, 'Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA', Genome Research, vol. 18, no. 1, pp. 19-29. https://doi.org/10.1101/gr.6883307
Korshunova, Yulia ; Maloney, Rebecca K. ; Lakey, Nathan ; Citek, Robert W. ; Bacher, Blaire ; Budiman, Arief ; Ordway, Jared M. ; McCombie, W. Richard ; Leon, Jorge ; Jeddeloh, Jeffrey A. ; Mcpherson, John Douglas. / Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. In: Genome Research. 2008 ; Vol. 18, No. 1. pp. 19-29.
@article{70dbb6cea2b94132b083c9bcfeb2838a,
title = "Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA",
abstract = "Cytosine-methylation changes are stable and thought to be among the earliest events in tumorigenesis. Theoretically, DNA carrying tumor-specifying methylation patterns escape the tumors and may be found circulating in the sera from cancer patients, thus providing the basis for development of noninvasive clinical tests for early cancer detection. Indeed, using methylation-specific PCR-based techniques, several groups reported the detection of tumor-associated methylated DNA in the sera from cancer patients with varying clinical success. However, by design, such analytical approaches allow assessment of the presence of molecules with only one methylation pattern, leaving the bigger picture unexplored. The limited knowledge about circulating DNA methylation patterns hinders the efficient development of clinical methylation tests and testing platforms. Here, we report the results of a comprehensive methylation pattern analysis from breast cancer clinical tissues and sera obtained using massively parallel bisulphite pyrosequencing. The four loci studied were recently discovered by our group, and demonstrated to be powerful epigenetic biomarkers of breast cancer. The detailed analysis of more than 700,000 DNA fragments derived from more than 50 individuals (cancer and cancer-free) revealed an unappreciated complexity of genomic cytosine-methylation patterns in both tissue derived and circulating DNAs. Both tumor and cancer-free tissues (as well as sera) contained molecules with nearly every conceivable cytosine-methylation pattern at each locus. Tumor samples displayed more variation in methylation level than normal samples. Importantly, by establishing the methylation landscape within circulating DNA, this study has better defined the development challenges facing DNA methylation-based cancer-detection tests.",
author = "Yulia Korshunova and Maloney, {Rebecca K.} and Nathan Lakey and Citek, {Robert W.} and Blaire Bacher and Arief Budiman and Ordway, {Jared M.} and McCombie, {W. Richard} and Jorge Leon and Jeddeloh, {Jeffrey A.} and Mcpherson, {John Douglas}",
year = "2008",
month = "1",
doi = "10.1101/gr.6883307",
language = "English (US)",
volume = "18",
pages = "19--29",
journal = "Genome Research",
issn = "1088-9051",
publisher = "Cold Spring Harbor Laboratory Press",
number = "1",

}

TY - JOUR

T1 - Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA

AU - Korshunova, Yulia

AU - Maloney, Rebecca K.

AU - Lakey, Nathan

AU - Citek, Robert W.

AU - Bacher, Blaire

AU - Budiman, Arief

AU - Ordway, Jared M.

AU - McCombie, W. Richard

AU - Leon, Jorge

AU - Jeddeloh, Jeffrey A.

AU - Mcpherson, John Douglas

PY - 2008/1

Y1 - 2008/1

N2 - Cytosine-methylation changes are stable and thought to be among the earliest events in tumorigenesis. Theoretically, DNA carrying tumor-specifying methylation patterns escape the tumors and may be found circulating in the sera from cancer patients, thus providing the basis for development of noninvasive clinical tests for early cancer detection. Indeed, using methylation-specific PCR-based techniques, several groups reported the detection of tumor-associated methylated DNA in the sera from cancer patients with varying clinical success. However, by design, such analytical approaches allow assessment of the presence of molecules with only one methylation pattern, leaving the bigger picture unexplored. The limited knowledge about circulating DNA methylation patterns hinders the efficient development of clinical methylation tests and testing platforms. Here, we report the results of a comprehensive methylation pattern analysis from breast cancer clinical tissues and sera obtained using massively parallel bisulphite pyrosequencing. The four loci studied were recently discovered by our group, and demonstrated to be powerful epigenetic biomarkers of breast cancer. The detailed analysis of more than 700,000 DNA fragments derived from more than 50 individuals (cancer and cancer-free) revealed an unappreciated complexity of genomic cytosine-methylation patterns in both tissue derived and circulating DNAs. Both tumor and cancer-free tissues (as well as sera) contained molecules with nearly every conceivable cytosine-methylation pattern at each locus. Tumor samples displayed more variation in methylation level than normal samples. Importantly, by establishing the methylation landscape within circulating DNA, this study has better defined the development challenges facing DNA methylation-based cancer-detection tests.

AB - Cytosine-methylation changes are stable and thought to be among the earliest events in tumorigenesis. Theoretically, DNA carrying tumor-specifying methylation patterns escape the tumors and may be found circulating in the sera from cancer patients, thus providing the basis for development of noninvasive clinical tests for early cancer detection. Indeed, using methylation-specific PCR-based techniques, several groups reported the detection of tumor-associated methylated DNA in the sera from cancer patients with varying clinical success. However, by design, such analytical approaches allow assessment of the presence of molecules with only one methylation pattern, leaving the bigger picture unexplored. The limited knowledge about circulating DNA methylation patterns hinders the efficient development of clinical methylation tests and testing platforms. Here, we report the results of a comprehensive methylation pattern analysis from breast cancer clinical tissues and sera obtained using massively parallel bisulphite pyrosequencing. The four loci studied were recently discovered by our group, and demonstrated to be powerful epigenetic biomarkers of breast cancer. The detailed analysis of more than 700,000 DNA fragments derived from more than 50 individuals (cancer and cancer-free) revealed an unappreciated complexity of genomic cytosine-methylation patterns in both tissue derived and circulating DNAs. Both tumor and cancer-free tissues (as well as sera) contained molecules with nearly every conceivable cytosine-methylation pattern at each locus. Tumor samples displayed more variation in methylation level than normal samples. Importantly, by establishing the methylation landscape within circulating DNA, this study has better defined the development challenges facing DNA methylation-based cancer-detection tests.

UR - http://www.scopus.com/inward/record.url?scp=38049073696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049073696&partnerID=8YFLogxK

U2 - 10.1101/gr.6883307

DO - 10.1101/gr.6883307

M3 - Article

C2 - 18032725

AN - SCOPUS:38049073696

VL - 18

SP - 19

EP - 29

JO - Genome Research

JF - Genome Research

SN - 1088-9051

IS - 1

ER -